There are currently more than 7 million patients taking a direct oral anticoagulant (DOAC),
with more new prescriptions per year than warfarin. Despite impressive efficacy and safety …

Direct oral anticoagulants (DOACs) have been a welcome addition to clinical practice due to
the practical advantages they confer over traditional anticoagulants. In many countries …

The treatment of acute venous thromboembolism (VTE) is being completely modified with
the development of direct oral anticoagulants (DOACs). Rivaroxaban, apixaban and …

Objective: To review clinical data on direct oral anticoagulants (DOACs) used in the acute
treatment of venous thromboembolism (VTE) as well as practical considerations when using …

In clinical practice, direct oral anticoagulants (DOACs) are increasingly used for venous
thromboembolism treatment and prevention. A substantial proportion of patients with venous …

Abstract Purpose of Review The purpose of this review is to examine the safety and
effectiveness of direct oral anticoagulants and provide recommendations for the treatment of …

726 Circulation February 18, 2014 and pulmonary embolism for whom outpatient treatment
is feasible, and this is likely to further facilitate outpatient treatment when observational …

Background There is scarce evidence on the effectiveness and safety of recommended-
dose direct acting oral anticoagulants (DOACs) in obese patients with venous …

Abstract Background Direct oral anticoagulants (DOACs) are the preferred treatment for
venous thromboembolism (VTE). However, DOAC use in patients with a BMI greater than 40 …

The advent of direct oral anticoagulants (DOACs) has revolutionized anticoagulation
management in both stroke prevention and venous thromboembolism (VTE) …